InsidersTradesSigma
Explore the detailed record of transactions filed by HILZINGER KURT J, Director. Insider active across 1 company, notably Outlook Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €221k. Activity tracked since 22 February 2022. The latest transaction was filed on 1 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Kurt J. Hilzinger serves as a Board Member at Outlook Therapeutics, Inc. He contributes to the governance of the company by participating in board meetings and providing his expertise in strategic decisions. Outlook Therapeutics is a biopharmaceutical company specializing in developing treatments for eye diseases.